My ePortfolio Register   

EHA 2010: Experts discuss treatment of elderly cancer patients

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 30.06.10
Views: 8249
Rating:

Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux

Healthcare experts discuss the care of the elderly in haemato-oncology, looking at the current situation across Europe and what is needed to change the treatment of older patients.

This interview is supported by an unrestricted educational grant from Celgene.

Click on the links below to see more from the participants in this round table debate:
Prof. Sullivan talks to ecancertv about ageism in cancer treatment.
Prof. Sullivan talks about innovation in cancer drug development.
Prof. Sullivan discusses UK cancer reform strategy.
Prof. Sullivan speaks about prioritisation in cancer research.
A presentation from Prof. Sullivan about cancer research priorities.
Prof. Fenaux discusses myelodysplastic syndromes (MDS).
Prof. Fenaux speaks about innovation in the treatment of MDS.
Prof. Fenaux on the epigenetics of MDS.
Prof. Fenaux explains the benefits of azacitidine for treatment of MDS.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence